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Abstract 
Objective:  To quantify salivary creatinine levels patients with end-stage renal disease 
(ESRD) before, during, and after hemodialysis sessions. Material and Methods: Sixty-
eight individuals, aged between 4 and 25 years, were selected, and among these, 34 were 
diagnosed with ESRD and were undergoing hemodialysis (Group 1) and 34 were 
clinically healthy patients (Group 2). Saliva samples were collected before, during, and 
after hemodialysis sessions for Group 1 and compared with those of Group 2. Stimulated 
saliva flow rate (SSFR), buffer capacity (BC), pH, and salivary creatinine levels were 
determined. Shapiro-Wilk test, followed by the Friedman, Mann-Whitney and ANOVA 
tests were used to analyze the variables. Results: Mean SSFR values of Group 1 at the 
three stages of hemodialysis sessions did not differ from those of Group 2. Furthermore, 
BC and pH values were within their normal limits, and no difference was detected 
between the two groups. Mean salivary creatinine levels at baseline and during 
hemodialysis were significantly higher in Group 1 that in Group 2, but these values 
were not different between Groups at the end of hemodialysis. Conclusion: Salivary 
creatinine levels reduce significantly after hemodialysis sessions suggesting that saliva 
may be used to monitor the efficiency of hemodialysis or even indicate the moment at 
which it should start. 
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Introduction 
Saliva provides several innate and acquired defense factors that can inhibit bacterial invasion, 
growth, and metabolism by different mechanisms [1,2] such as bacterial adherence and streptococci 
acid production [3]. Several studies have so far investigated many biological determinants that may 
influence biofilm cariogenicity [4,5], such as saliva flow and composition [6]. A constant salivary 
flow efficiently eliminates microorganisms from the oral cavity; conversely, a reduced flow may 
easily favor microbial growth, followed by teeth deterioration [7]. Some salivary proteins such as 
lysozymes, lactoperoxidase, immunoglobulins, agglutinines, mucins, and lactotransferrin have 
antibacterial effects [8] and hence help in preventing oral diseases. 
Saliva is also an extremely useful biological fluid for prognosis, laboratory, or clinical 
diagnosis and monitoring systemic diseases [9]. Salivary biomarkers are employed for screening 
purposes in epidemiological studies [10] and are being used to monitor and detect various oral and 
systemic diseases such as breast cancer [11], lung cancer [12], celiac disease [13], and chronic renal 
failure [14]. Recent studies on end-stage renal disease (ESRD) reported a series of salivary markers 
associated with ESRD. The list of markers included cortisol, nitrite, uric acid, sodium, chloride, pH, 
amylase, and lactoferrin [15].  
In the case of ESRD, measurement of serum creatinine in individual patients provides an 
estimate of disease progression and may determine the effects of therapy. It may be used to predict 
when dialysis becomes necessary and also indicate progress of ESRD [16]. Since serum constituents 
may reach the saliva [17], the goal of this study was to quantify the salivary creatinine in patients 
with ESRD before, during, and after hemodialysis sessions. 
 
Material and Methods 
All individuals included in the study signed informed consent form, according to norms of 
the Ethical Committee on Research of the Center for Health and Biological Sciences of the São 
Leopoldo Mandic, Campinas, SP, Brazil, following Resolution 196/96 of the Health National 
Council, register no. 05/452. If the individual was under age, their parents/guardians signed the 
informed consent form. 
Thirty-four unrelated ESRD patients, (23 male and 11 female, age group 4-25 years, with 
more than 30 months of hemodialysis sessions at the Hospital Pequeno Príncipe, Curitiba PR Brazil, 
formed the group one (G1). The control group (G2) consisted of 34 healthy subjects, matched for age 
and gender, from the Health Unit Nossa Senhora da Conceição, Campo Magro, PR, Brazil. All 
individuals were examined by two dentists. The consistency of each examiner (inter- and intra-
examiner reproducibility) was assessed by duplicate examinations conducted on 10% of the sample; 
the kappa test measured reliability at 95% probability.  
Saliva samples from both groups were obtained by spitting [18]. For the G1, saliva was 
collected in the hemodialysis room before connecting the hemodialysis machine, during the 
hemodialysis, and after switching off the hemodialysis machine. Saliva samples for G2 were collected 
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before the dental clinical care at the Health Unit Nossa Senhora da Conceição, as they sat in the 
dental chair. Salivary flow was evaluated by means of stimulated saliva collection, or rather, by 
mechanical masticatory stimulation using a standard (1.5 cm) piece of sterile rubber tourniquet 
during continuous mastication by the patient for 6 minutes. Saliva produced during the first minute 
of stimulation was discarded. During the following 5 minutes, individuals expelled saliva into a 
sterile universal collector vial that had been previously weighed with Marte® analytical scales, 
model AL 500 (São Paulo SP, Brazil). Stimulated saliva flow rate (SSFR) was evaluated using the 
gravimetric method and expressed in mL/min [19]. Furthermore, pH was measured by a portable 
pH meter (Digimed Analytical Instrumentation Inc., São Paulo, SP, Brazil). Salivary buffering 
capacity (BC) was determined with Caritest®–SL kit (Technew Com. e Ind. Ltda., Rio de Janeiro, RJ, 
Brazil). Moreover, 1 mL of the collected saliva was added to a flask containing 3 mL of 0.005N HCl 
solution. Sample readings were performed following the manufacturer’s instructions.  
The remaining saliva samples were centrifuged (3,000 g for 10 min). Salivary creatinine was 
measured using the alkaline picrate colorimetric method, Creatinina K – Labtest Diagnóstica, on a 
Bioplus spectrophotometer (Hoffmann-La Roche, Basel, Switzerland). Creatinine reacts with picrate 
in an alkaline medium to form a red complex measured photometrically. The addition of an acidulant 
lowers pH to 5.0 and causes the decomposition of creatinine picrate. The reading of the samples 
takes place at 30 and 90 seconds and the difference between the two readings provides the true 
creatinine rate. All tests were performed three times. 
The Shapiro-Wilk Test was employed for the normality analysis. Friedman test, followed by 
nonparametric multiple comparisons, at 0.05 significance level, was used. The Mann-Whitney and 
ANOVA tests were employed when statistically significant rates (p ≤ 0.05 and confidence interval 
[CI] 95%) occurred. 
 
Results 
Sixty-eight participants, 34 patients with ESRD (Group 1) and 34 healthy subjects (Group 
2), participated in the current analysis. Twenty-three subjects were male (67.6%) and 11 were female 
(32.4%) in each group. The average age was 13.4 years in both groups. Five of the 34 patients in the 
study did not participate in the analysis due to the following causes: two of the patients were unable 
to produce a salivary flow with stimulation, two displayed behavioral resistance, and one died before 
the collection date. 
Mean SSFR rates of ESRD patients at the three stages of hemodialysis sessions did not differ 
significantly from those of healthy patients (Group 2). In addition, BC was normal in the three stages 
of hemodialysis sessions and did not differ between both groups. Initial salivary pH of the ESRD 
group was higher at the start of the hemodialysis sessions and decreased during and after the 
sessions. Nonetheless, it remained higher than the salivary pH of the Group 2, albeit without 
statistically significant differences.  
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Mean salivary creatinine levels before  and during hemodialysis were significantly higher in 
ESRD patients compared to  healthy subjects  (p = 0.0063 and p = 0.0409, respectively), but these 
values were not different between groups at the end of hemodialysis (p = 0.4569). ANOVA test 
showed a difference between the three sessions of hemodialysis for creatinine (p = 0.0531). 
Descriptive statistics of the variables analyzed according to the groups are given in Tables 1 and 2. 
 
Table 1. Descriptive statistics of the variables in the two groups. 
 ESRD Patients Mean Value Median Standard Deviation Standard Error 
SSFR (mL/min) Initial 29 0.93 0.77 0.67 0.12 
SSFR (mL/min) During 29 0.96 0.85 0.69 0.13 
SSFR (mL/min) After 29 0.97 0.95 0.60 0.11 
pH Initial 29 8.01 8.03 0.34 0.06 
pH During 29 7.69 7.73 0.31 0.06 
pH After 29 7.75 7.77 0.40 0.07 
 Control Group     
SSFR  34 0.89 0.84 0.42 0.07 
pH  34 7.39 7.41 0.25 0.04 
Ssfr: Stimulated Salivary Flow Rate; Cre: Creatinine. 
 
Table 2. Distribution of average creatinine values for each group according to the time of saliva 
collection. 
Groups 
Creatinine 
Initial During After 
Mean Value 
(mg/dl) 
CI 95% Mean Value 
(mg/dl) 
CI 95% Mean Value 
(mg/dl) 
CI 95% 
LL UL LL UL LL UL 
ESRD Patients 1.26 aA 0 3.23 0.28 abA 0.22 0.34 0.23 bB 0.17 0.28 
Control  0.20 B 0.15 0.24       
 CI: Confidence Interval; LL: lower limit; UL: Upper limit; The same small letters in the lines and the same capital letters in the columns 
show no statistical difference;  Mann–Whitney U and ANOVA tests. 
 
Discussion 
The complex oral fluid called saliva has long been acknowledged as a clinically informative 
biological fluid that is highly useful for novel approaches in the diagnosis of diseases. The many 
advantages of saliva comprise good cooperation with patients, non-invasive collection, low cost, easy 
transportation and storage, early detection of disease [20], and correlation with levels of the same 
metabolites in blood [21]. 
Biochemical analysis of saliva and blood have two main objectives: to identify individuals 
with disease and evaluate the prognosis of the same during treatment [22]. Salivary fluid 
composition may be affected by different forms of stimulation, time of day, diet, age, gender, a variety 
of disease conditions, and several pharmacological agents [17,23]. Whole saliva is a mixed fluid that 
is derived predominantly from major and minor salivary glands. It contains gingival crevicular fluid, 
mucosal transudations, expectorated bronchial, and nasal secretions, serum and blood derivatives 
from oral wounds, bacteria and bacterial products, viruses and fungi, desquamated epithelial cells, 
cellular components, and food debris [8,21] besides urea, ammonia, uric acid, glucose, cholesterol, 
fatty acids, triglycerides, phosphorus, neutral lipids, glycolipids, amino-acids, and steroid hormones 
[24]. 
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Earlier researchers had reported a series of salivary markers associated with ESRD. The list 
included cortisol, nitrite and uric acid, sodium, chloride, pH, amylase, and lactoferrin [15]. Salivary 
phosphate has also been widely used as a clinical biomarker for hyperphosphatemia and these levels 
correlated well with serum creatinine and glomerular filtration rate [25]. Some authors reported 
that salivary creatinine concentration in individuals with chronic renal failure was associated with 
increased serum creatinine levels, which is not observed in healthy subjects [26]. Therefore, salivary 
creatinine may be a marker for kidney diseases. 
The current assay showed that initial salivary creatinine of the ESRD patients was 
significantly higher before hemodialysis. In the course of the session and after that there was a 
significant decrease in creatinine. At the end of the hemodialysis session, salivary creatinine 
concentration remained higher but near the values observed in healthy individuals. The hemodialysis 
session clearly caused a significant decrease in the amount of salivary creatinine in ESRD patients.  
Previous studies tested colorimetric test strips to monitor salivary nitrate and uric acid 
before and after hemodialysis [27]. At this point, the development of test strips to monitor the 
salivary creatinine may be interesting to indicate when hemodialysis session must begin or end, 
saving the patient time and providing great benefits to health services, particularly in primary health 
care. 
Since the current research is related to SSFR, BC and pH, an inert material was employed to 
avoid interfering with the patient’s salivary flow. This is why a piece of latex hose was used. During 
the acquisition of saliva samples, the patients from the two groups were seated. ESRD patients were 
sitting on the same chairs used for the hemodialysis sessions. Results on SSFR, BC, and pH revealed 
that the variables at the three sessions of hemodialysis presented no significant difference from the 
results of healthy subjects. These findings were unexpected as they are in direct contrast with the 
findings from most studies in the literature [28,29], which have reported a significantly reduced 
mean salivary flow in uremic patients. According to these authors, the quantitative change in 
salivary flow is directly associated with uremia involving salivary glands and a lower degree of 
hydration due to the restriction of fluid ingestion. 
Finally, salivary research is a dynamic field. General and oral health will largely benefit from 
the development and improvement of new research techniques in this field. 
 
Conclusion 
Mean rates for SSFR, BC, and pH were not different between ESRD patients and healthy 
subjects. Salivary creatinine decreased significantly after hemodialysis sessions suggesting that saliva 
may be used to monitor the efficiency of hemodialysis or even indicate the moment at which it should 
start. 
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